Zambon in the USA

Zambon USA

Zambon USA Team

Together with their European colleagues, the American team has been laying the groundwork in preparation for two commercial launches, pending positive data and receiving the necessary regulatory approvals.

USA Team

Chief Commercial Officer USA at Zambon USA Ltd. & Head of Global Marketing Specialty Care at Zambon


Mr. Shadday has more than 20 years of global commercial expertise in strategic and operational marketing and sales functions with leadership roles in US, Europe, Latin America and Asia Pacific.

He is responsible for the development of Zambon’s USA affiliate and leading the commercial organization for Zambon’s US CNS, anti-infective and severe respiratory disease portfolios. In his role as Head of Global Marketing Specialty Care, he is responsible for Zambon’s global CNS and severe respiratory drug portfolios. Prior, he served as the Chief Commercial Officer at Breath Therapeutics, until the company’s acquisition by Zambon SpA in 2019. Earlier, Mr. Shadday was the Global Marketing Lead at Vertex for its next-generation corrector programs for the treatment of cystic fibrosis. Previously, he served as Vice President and Global Business Leader at Lundbeck and led the global product launch of Brintellix/Trintellix, a novel antidepressant and key brand. Prior, Mr. Shadday served as Director of International and Global Commercial Strategy at Gilead Sciences and was responsible for the hepatitis, anti-fungal and respiratory therapeutic franchises. At Gilead, he also oversaw the U.S. and international commercial teams for the global commercial launch of Viread for Hepatitis B.  Earlier in his career, Mr. Shadday held several commercial positions with Novartis in Europe, the US and South America. 

Mr. Shadday earned a Bachelor of Arts degree in Economics from Yale University and is a graduate of the Ecole Supérieure de Commerce de Paris. He holds a dual US and French Citizenship and is fluent in French, German, English and Spanish. 

Head of US Marketing Strategy & Launch Readiness
Device Trainer US
BOSTON Clinical Site Liaison, NCFB Project Management Support
Vice President, Market Access & HEOR
D. Robert
Global Patient Advocacy Head Rare Diseases
McGrain, MS RRT
Director, Health Economics and Outcomes Research
Michael E.
Minshall, MPH
Vice President, Corporate Communication
Vice President, Medical Affairs
Shahid J.
Siddiqui, MD
Clinical Trial Manager
Zambon USA Ltd.
One Broadway, 14th Floor Cambridge, MA 02142
+1 617 294 6608 / 833 4ZAMBON (833 492 6266) US Only
Visit Us
We will be at ISHLT 2022 in Boston!
April 27-30, 2022 (Booth 526)

We will be at ATS 2022 in San Francisco!
May 13-18, 2022 (Clinical Trials Booth 10)